0
United States ( Change Country )

SB939 (Pracinostat)

Catalog No.S1515 1 Review(s)
Price Stock Quantity
$ 210
$ 370
$ 870
 
processing...
You can order by phone, email or fax

Tel: +1-832-582-8158    Fax: +1-832-582-8590
Email: sales@selleckchem.com

Free Overnight Delivery on all orders over $ 500.

Order SB939 (Pracinostat) now
and get it on .

SB939 (Pracinostat) Chemical Structure

Recommended Products

  • Naftopidil Dihydrochloride

    Naftopidil Dihydrochloride is an antihypertensive agent.

  • Silodosin (Rapaflo)

    Silodosin(Rapaflo) is an α1-adrenoceptor antagonist with high uroselectivity.

  • Salbutamol sulfate (Albuterol)

    Salbutamol (Albuterol) is a short-acting β2-adrenergic receptor agonist with an IC50 of 8.93 µM.

  • AZD1152

    AZD1152 is a highly potent and selective Aurora B inhibitor with a Ki of 0.36 nM.

  • Elesclomol

    HSP-70 Inducer

  • LBH589 (Panobinostat)

    LBH589 (Panobinostat) is a HDAC inhibitor, IC50 for inhibition of proliferation in MOLT-4 cells is approximately 5 μM and for Reh cells is approximately 20 μM.

  • MS-275 (Entinostat)

    MS-275 (Entinostat) is a potent HDAC inhibitor with IC50 of 0.3 and 8µM for HDAC1 and HDAC3, respectively.

  • Trichostatin A (TSA)

    Inhibitor of HDAC, HDAC inhibitory activity of TSA was similar in all cell lines with mean ± SD IC50 of 2.4 ± 0.5 nm (range, 1.5–2.9 nm)

  • Vorinostat (SAHA)

    Vorinostat also known as SAHA, Zolinza, MK-0683 is an HDAC inhibitor. Vorinostat CAS No 149647-78-9 with purity >99% & solubility DMSO is available.

  • VX-680 (MK-0457, Tozasertib)

    VX-680 (MK-0457, Tozasertib) is the inhibitor of Aurora-A,-B,-C kinases with apparent inhibition constant values of 0.6,18,4.6 nM respectively.

Biological Activity

Information SB939 (Pracinostat) is a potent HDAC inhibitor of HDACs class I, II and IV with Ki of 19 to 48 nM, 16 to 247 nM, and 43 nM, with the exception of HDAC6.
Targets HDACs I HDACs II (except HDAC6) HDACs IV
IC50 19 to 48 nM (Ki) 16 to 247 nM (Ki) 43 nM (Ki) [1]
In vitro SB939 had no activity against the class III isoenzyme SIRT I. SB939 is more sensitive to cutaneous T-cell lymphoma cells and leukemia cells, with IC50 from 50 nM (H9 cutaneous T-cell lymphoma cells) to 170 nM (HEL92.1.7 erythroleukemia cells), compared to colon and prostate cancer cell lines. SB939 has no inhibitory to normal human dermal fibroblasts at concentrations up to 100 μM. SB939 induces acetylated (K9/K14) histone H3, acetylation of α-tubulin, decreased retinoblastoma serine phosphorylation on S807/811 and induction of cell cycle arrest in HCT-116 cells. [1]
In vivo SB939 has greater pharmacokinetic properties and oral bioavailability than SAHA in nude mice. SB939 selectively accumulates in tumor tissue in HCT-116 xenografts with dosed of 50 mg/kg. SB939 shows great antitumor activity with 94% TGI in HCT-116 tumor-bearing mice at 100 mg/kg. Furthermore, in APCmin mice, SB939 inhibits adenoma formation, hemocult scores, and increased hematocrit values more effectively than 5-fluorouracil. [1] SB939 also has broad antitumor activity and highly efficacious in tumor models (HCT-116, PC-3, A2780, MV4-11, Ramos). SB939 has high and dose-proportional oral exposures and very good ADME (absorption, distribution, metabolism, and excretion), safety, and pharmaceutical properties. [2]
Clinical Trials SB939 is currently in Phase II clinical trial in patients with translocation-associated recurrent/metastatic sarcomas.
Features SB939 is Singapore's first locally developed anti-cancer compound to enter Phase I clinical trials.

Protocol

Kinase Assay: [1]

HDAC enzyme assay For in vitro studies, SB939 is dissolved in DMSO (stock concentration, 10 mM). The HDAC enzyme assay for class I, II and IV isoenzymes is performed in black 384-well plates using the fluorescent-based HDAC activity assay. The reaction contained 2.5 or 5 μL of the HDAC isoenzyme, assay buffer (25 mM Tris-HCl, pH 7.5; 137 mM NaCl; 2.7 mM KCl, 1 mM MgCl2 and 1 mg/mL BSA), different concentrations of SB939 or DMSO, and the fluorogenic deacetylase substrate Flour de LysTM in a total reaction volume of 33 μL. The concentration of substrate used in the reaction varied according to the isoenzyme used (50 μM for HDAC6, 250 μM for HDACs 2-5 and 11 or 625 μM for HDAC1 and HDACs 7-10). After 2 hours incubation at room temperature 16 μL of Flour de LysTM developer are added and a fluorophore is generated where substrate deacetylation has occured. The emitted light is measured (at 460 nm) in a microplate reader after additional 10 min of incubation (excitation 360 nm). IC50 values are generated using the XLfit software, Ki values are obtained using the Cheng-Prusoff equation: IC50/(1+[concentration of the subs trate]/ Km).

Cell Assay: [1]

Cell lines: Colo205, HCT-116, A2780, PC3, A2780, DU145, MCF7, BT549, MDA-MB231, T47D, NHI-H460, A549 cells and etc.
Concentrations: 1.5 nM to 100 μM.
Incubation Time: 96 hours
Method: Cells are seeded in 96-well plates at a predetermined optimal density, in the log growth phase, and rested for 24 hours (adherent cells) or 2 hours (suspension cells), respectively, before treatment with SB939. All experiments are done for 96 hours, with 1% solvent, using either the CyQUANT Cell proliferation assay kit for adherent cells or the CellTiter96 Aqueous One solution cell proliferation kit for suspension cells, according to the manufacturer's instructions, in a total volume of 100 μL with SB939 concentrations from 100 μM to 1.5 nM. IC50 are determined using the XLfit software.

Animal Study:[1]

Animal Models: HCT-116 xenograft models are established in female BALB/c nude mice.
Formulation: SB939 is prepared in 0.5% methylcellulose (w/v) and 0.1% Tween-80 in water for oral dosing. For pharmacokinetic analysis, SB939 is dissolved in normal saline for i.v. injection.
Dosages: 25, 50, 75, or 100 mg/kg
Administration: Administered by oral gavage or i.v. injection

References

Molecular Weight (WM): 358.48
Formula:

C20H30N4O2

CAS No.: 929016-96-6
Synonyms:
N/A
Dissolve in (25°C): DMSO ≥72mg/mL 
Water <1mg/mL 
Ethanol ≥72mg/mL 
Storage: 2 years-20°CPowder
1 week-4°Cin DMSO
1 month-80°in DMSO

Quality Control & MSDS

View current batch:
COA H-NMR HPLC COA H-NMR HPLC

Related Inhibitors

Recommended Screening Libraries

We have 1 customer reviews of SB939 (Pracinostat).

  • (0)
  • (1)
  • (0)
  • (0)
  • (0)
  • (0)
  • (0)
  • (0)
  • (0)

Average Customer Review

(1 customer reviews)

  • Click to enlarge

    Breast cancer cells were treated with the indicated concentrations of SB939.

     

     

  • Breast cancer cells were treated with the indicated concentrations of SB939.

     

     

  • Data independently produced by Dr. Zhang of Tianjin Medical University
    SB939 (Pracinostat) purchased from Selleck

Our scientific support team are available to answer any questions or queries.
Fill out an inquiry form for SB939 (Pracinostat) for help.

Quality Matters

Check our customer reviews


Breast cancer cells were treated with the indicated concentrations of SB939.

 

 

Data independently produced by Dr. Zhang of Tianjin Medical University

Free Sample and Reward

We give free samples and rewards to people who would like to provide us useful scientific data(western blot, etc.) > See Details

Recently Viewed Items

Keywords:buy SB939 (Pracinostat) | SB939 (Pracinostat) supplier | purchase SB939 (Pracinostat) | SB939 (Pracinostat) cost | SB939 (Pracinostat) manufacturer | order SB939 (Pracinostat) | SB939 (Pracinostat) distributor